+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer

Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer

Biomed Research International 2017: 7869802

Gastric cancer is the fifth most common cancer and the third cause of cancer death. The clinical outcomes of the patients are still not encouraging with a low rate of 5 years' survival. Often the disease is diagnosed at advanced stages and this obviously negatively affects patients outcomes. A deep understanding of molecular basis of gastric cancer can lead to the identification of diagnostic, predictive, prognostic, and therapeutic biomarkers. This paper aims to give a global view on the molecular classification and mechanisms involved in the development of the tumour and on the biomarkers for gastric cancer. We discuss the role of E-cadherin, HER2, fibroblast growth factor receptor (FGFR), MET, human epidermal growth factor receptor (EGFR), hepatocyte growth factor receptor (HGFR), mammalian target of rapamycin (mTOR), microsatellite instability (MSI), PD-L1, and TP53. We have also considered in this manuscript new emerging biomarkers as matrix metalloproteases (MMPs), microRNAs, and long noncoding RNAs (lncRNAs). Identifying and validating diagnostic, prognostic, predictive, and therapeutic biomarkers will have a huge impact on patients outcomes as they will allow early detection of tumours and also guide the choice of a targeted therapy based on specific molecular features of the cancer.

(PDF emailed within 0-6 h: $19.90)

Accession: 059604793

Download citation: RISBibTeXText

PMID: 29094049

DOI: 10.1155/2017/7869802

Related references

HDGF and ADAM9 are novel molecular staging biomarkers, prognostic biomarkers and predictive biomarkers for adjuvant chemotherapy in surgically resected stage I non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology 140(8): 1441-1449, 2014

Diagnostic, Prognostic, and Predictive Molecular Biomarkers and the Utility of Molecular Imaging in Common Gastrointestinal Tumors. Biomed Research International 2015: 890805, 2016

PI3K-AKT-mTOR pathway: Description, therapeutic development, resistance, predictive/prognostic biomarkers and therapeutic applications for cancer. Bulletin du Cancer 103(1): 18-29, 2016

Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer. Journal of Surgical Oncology 107(1): 15-22, 2013

Biomarkers in pancreatic cancer: diagnostic, prognostic, and predictive. Cancer Journal 18(6): 530-538, 2013

Epigenetic alterations as cancer diagnostic, prognostic, and predictive biomarkers. Advances in Genetics 71: 125-176, 2010

Synergistic role between p53 and JWA: prognostic and predictive biomarkers in gastric cancer. Plos One 7(12): E52348, 2013

Biomarkers for gastric cancer: prognostic, predictive or targets of therapy?. Virchows Archiv 464(3): 367-378, 2014

The Diagnostic, Prognostic, and Predictive Potential of MicroRNA Biomarkers in Colorectal Cancer. Current Colorectal Cancer Reports 8(1): 22-31, 2012

Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer. World Journal of Gastroenterology 20(14): 3858-3874, 2015

Prognostic and putative predictive biomarkers of gastric cancer for personalized medicine. Diagnostic Molecular Pathology 22(3): 127-137, 2014

Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer. Genes, Chromosomes and Cancer 52(4): 356-369, 2013

Prognostic Value of Inflammatory Biomarkers in Gastric Cancer Patients and the Construction of a Predictive Model. Digestive Surgery 2018: 1-10, 2018

How prognostic and predictive biomarkers are transforming our understanding and management of advanced gastric cancer. Oncologist 19(10): 1046-1055, 2015

Prognostic and predictive potential molecular biomarkers in colon cancer. Chirurgia 106(2): 177-185, 2011